10x Genomics' talented, dedicated science professionals have a distinguished record of creating innovative instruments, reagents and software that analyze biological systems at a resolution that ...

The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Receive News & Ratings for 10x Genomics ...

In other recent news, 10X Genomics announced preliminary fourth ... its GeoMx Digital Spatial Profiler and related instruments, reagents, and services within the United States for RNA and protein ...

Arc Institute continues its work to generate and share large-scale, high-quality datasets of cell state before and after ...

Wall Street expects a year-over-year increase in earnings on lower revenues when 10x Genomics (TXG) reports results for the quarter ended March 2025. While this widely-known consensus outlook is ...

10x Genomics reported revenues of $165 million ... develops and manufactures specialized reagents, instruments, and services that help researchers study biological processes and enable diagnostic ...

Our facility is equipped with state-of-art instruments, including the 10X Genomics Chromium X which enables high-throughput single cell gene expression profiling, 10X Genomics Xenium platform, and the ...

The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Receive News & Ratings for 10x Genomics ...

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East ...

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell ...

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the life sciences tools & services industry, including 10x Genomics (NASDAQ:TXG) and its peers.